Compare Danaos Corporation (DAC) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Danaos Corporation trades at $170.2 (market cap $2.99B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B). The key difference: Danaos Corporation is the larger of the two by market cap, and Danaos Corporation pays a 2.43% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| DAC | SLS | |
|---|---|---|
Market Cap | $2.99B | $2.28B |
Volume | 328,260 | 3,128,960 |
Sector | Industrials | Health |
52-Week High | $170.22 | $15.46 |
52-Week Low | $84.05 | $1.39 |
Typical Hold Time | 25 Days | — |
Enterprise Value | $2.97B | $2.15B |
Dividend Yield | 2.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaos Corporation (DAC) trades at $164.48, down 0.88% on the day, with strong fundamental metrics including a low P/E of 5.57 and robust profitability margins. The stock shows a bullish technical trend, trading above key moving averages, with recent earnings consistently beating expectations. The company maintains strong cash flow generation and has declared multiple dividends, reflecting financial health and shareholder returns.
The outlook remains positive given DAC's undervaluation, earnings momentum, and dividend payments. Key risks include shipping industry cyclicality and global trade volatility. Analyst consensus is evenly split between Buy and Hold, indicating cautious optimism amid strong fundamentals and technical strength.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
